Drugs for malaria, osteoporosis, and diabetes are currently under clinical trials and will soon hit the markets to curb the ever increasing death toll, said Dr. Harsh Vardhan, Union Minister for Science and Technology and Earth Sciences, after visiting Central Drug Research Institute (CDRI), Lucknow, a wing of the Council of Scientific and Industrial Research (CSIR) .
According to the BJP leader, the Indian pharmaceutical sector has conducted several tests to develop candidate drugs against the most lethal diseases in India responsible for several deaths every year.
On an optimistic note, he said that scientists have shown promising results that are in compliance with the Prime Minister Narendra Modi’s mission of making India as one of the biggest destination for the drug discovery in the world by 2020.
“I am confident that the drug laboratories under the CSIR are capable of backing up the Swasth Swachh Bharat Mission. Our scientists are focussing on both infectious and lifestyle diseases. We are developing next generation drugs, biologics, biosimilars, gene therapeutics, stem cell therapeutics, personalised medicine and multifunctional nanomedicine,” said Dr. Vardhan.
Reminding the discoveries of these prestigious institutions in the past he said that CSIR-CDRI, CSIR-Indian Institute of Chemical Technology (CSIR-IICT, Hyderabad) and CSIR-Indian Institute of Chemical Biology (CSIR-IICB, Kolkata) have discovered drugs for filaria, kala azar, tuberculosis and many more that too at cheap rate.
Diabetes results in slow death, however, the vector-borne malaria is a seasonal disease and takes many lives every year in India. Malaria hits the country in every rainy season and is about to hit the doors again. If scientists are able to release the drug for commercial use before the rainy season then it might save several lives.
In addition, Dr, Vardhan said that people were expecting CSIR laboratories to produce therapeutic and preventive measures for re-emerged infectious diseases like malaria and they will not let people down. Further, he added that government should encourage R&D team and increase funds for more innovations if India wants to become drug invention powerhouse by 2020 .